Table 2 Study population: N° of myomas per patient, total N° of myomas per group, type, and size of myomas at myomectomy in Group A (IBS®) and in Group B (Versapoint®) during a 2-year period June 2011–June 2013
N° Myomectomies: June 2011–June 2013 | ||
|---|---|---|
Group A IBS® (n = 76) | Group B Versapoint® (n = 51) | |
N° of myomas per patient | ||
1 | 66 (86.8 %) | 46 (90.2 %) |
> 1 | 10 (13.2 %) | 5 (9.8 %) |
N° total of myomas | 88 | 56 |
Type | ||
G0 | 28/88 (31.8 %) | 18/56 (32.1 %) |
G1 | 28/88 (31.8 %) | 18/56 (32.1 %) |
G2 | 32/88 (36.4 %) | 20/56 (35.8 %) |
Size (mm) | ||
< 30 | 61/88 (69.3 %) Group A1 | 35/56 (62.5 %) Group B1 |
> =30 | 27/88 (30.7 %) Group A2 | 21/56 (37.5 %) Group B2 |